CARLOS
SOLANO VERCET
CATEDRÁTICO/A DE UNIVERSIDAD
![Foto de CARLOS](/img/nophoto.png)
![Foto de KU Leuven](/img/noimage_org.png)
KU Leuven
Lovaina, BélgicaKU Leuven-ko ikertzaileekin lankidetzan egindako argitalpenak (9)
2024
-
Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation
The Lancet Haematology, Vol. 11, Núm. 2, pp. e147-e159
-
Treatment for First Cytomegalovirus Infection Post–Hematopoietic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blind, Randomized, Phase 3 Trial Comparing Maribavir With Valganciclovir
Clinical Infectious Diseases, Vol. 78, Núm. 3, pp. 562-572
-
Upper and/or Lower Respiratory Tract Infection Caused by Human Metapneumovirus After Allogeneic Hematopoietic Stem Cell Transplantation
Journal of Infectious Diseases, Vol. 229, Núm. 1, pp. 83-94
2023
2021
2020
-
Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell Malignancies
Frontiers in Immunology, Vol. 11
-
Polymorphisms within the ARNT2 and CX3CR1 genes are associated with the risk of developing invasive aspergillosis
Infection and Immunity, Vol. 88, Núm. 4
-
Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation
The Lancet Haematology, Vol. 7, Núm. 2, pp. e157-e167
2017
-
Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation
Bone Marrow Transplantation, Vol. 52, Núm. 3, pp. 372-380